Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy.

Grodzinsky, Anna; Arnold, Suzanne V; Wang, Tracy Y; Sharma, Praneet; Gosch, Kensey; Jones, Philip G; Bhatt, Deepak L; Steg, Philippe Gabriel; McGuire, Darren K; Cohen, David J; Spertus, John A; Chhatriwalla, Adnan K; Lind, Marcus; Graham, Garth; Kosiborod, Mikhail

Grodzinsky, Anna; Arnold, Suzanne V; Wang, Tracy Y; Sharma, Praneet; Gosch, Kensey; Jones, Philip G; Bhatt, Deepak L; Steg, Philippe Gabriel; McGuire, Darren K; Cohen, David J; Spertus, John A; Chhatriwalla, Adnan K; Lind, Marcus; Graham, Garth; Kosiborod, Mikhail.

Affiliation

Grodzinsky A; Saint Luke's Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO. Electronic address: agrodzinsky@gmail.com.
Arnold SV; Saint Luke's Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO.
Wang TY; Duke Clinical Research Institute, 2400 Pratt Street, Durham, NC.
Sharma P; Saint Luke's Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO.
Gosch K; Saint Luke's Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO.
Jones PG; Saint Luke's Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO.
Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, 75 Francis Street, Boston, MA.
Steg PG; University Paris Diderot, INSERM U1148, AP-HP, Paris, France.
McGuire DK; Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX.
Cohen DJ; Saint Luke's Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO.
Spertus JA; Saint Luke's Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO.
Chhatriwalla AK; Saint Luke's Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO.
Lind M; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden and Department of Medicine, NU-Hospital Organization, Uddevalla, Sweden.
Graham G; Aetna Foundation, University of Connecticut, Hartford, CT.
Kosiborod M; Saint Luke's Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO.

Am Heart J ; 182: 111-118, 2016 Dec.

Article in En | MEDLINE | ID: mdl-27914490

Subject(s)

Aspirin; Coronary Artery Disease; Diabetes Mellitus/epidemiology; Hemorrhage; Percutaneous Coronary Intervention; Pyridines; Aged; Aspirin/administration & dosage; Aspirin/adverse effects; Comorbidity; Coronary Artery Disease/diagnosis; Coronary Artery Disease/epidemiology; Coronary Artery Disease/therapy; Drug Therapy, Combination/adverse effects; Drug Therapy, Combination/methods; Drug Therapy, Combination/statistics & numerical data; Drug-Eluting Stents; Female; Hemorrhage/chemically induced; Hemorrhage/epidemiology; Humans; Long Term Adverse Effects/epidemiology; Male; Middle Aged; Percutaneous Coronary Intervention/adverse effects; Percutaneous Coronary Intervention/instrumentation; Percutaneous Coronary Intervention/methods; Platelet Aggregation Inhibitors/administration & dosage; Platelet Aggregation Inhibitors/adverse effects; Pyridines/administration & dosage; Pyridines/adverse effects; Registries/statistics & numerical data; Risk Assessment

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Coronary Artery Disease / Aspirin / Diabetes Mellitus / Percutaneous Coronary Intervention / Hemorrhage Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Am Heart J Year: 2016 Type: Article

Fulltext

XML

PubMed Links

Search on Google